Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations.

Gaedigk A, Tyndale RF, Jurima-Romet M, Sellers EM, Grant DM, Leeder JS.

Pharmacogenetics. 1998 Aug;8(4):305-13.

PMID:
9731717
2.

Ethnic variation in the prevalence of a common NAD(P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy.

Kelsey KT, Ross D, Traver RD, Christiani DC, Zuo ZF, Spitz MR, Wang M, Xu X, Lee BK, Schwartz BS, Wiencke JK.

Br J Cancer. 1997;76(7):852-4.

3.
4.

Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies.

Schulz WA, Krummeck A, Rösinger I, Eickelmann P, Neuhaus C, Ebert T, Schmitz-Dräger BJ, Sies H.

Pharmacogenetics. 1997 Jun;7(3):235-9.

PMID:
9241663
5.

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).

Traver RD, Siegel D, Beall HD, Phillips RM, Gibson NW, Franklin WA, Ross D.

Br J Cancer. 1997;75(1):69-75.

6.

A polymorphism in NAD(P)H:quinone oxidoreductase (NQO1): relationship of a homozygous mutation at position 609 of the NQO1 cDNA to NQO1 activity.

Ross D, Traver RD, Siegel D, Kuehl BL, Misra V, Rauth AM.

Br J Cancer. 1996 Sep;74(6):995-6. No abstract available.

7.

Identification of an NAD(P)H:quinone oxidoreductase polymorphism and its association with lung cancer and smoking.

Rosvold EA, McGlynn KA, Lustbader ED, Buetow KH.

Pharmacogenetics. 1995 Aug;5(4):199-206.

PMID:
8528266
8.
9.

Structure-specific endonucleolytic cleavage of nucleic acids by eubacterial DNA polymerases.

Lyamichev V, Brow MA, Dahlberg JE.

Science. 1993 May 7;260(5109):778-83.

PMID:
7683443
10.

Presence of a heterozygous substitution and its relationship to DT-diaphorase activity.

Kuehl BL, Paterson JW, Peacock JW, Paterson MC, Rauth AM.

Br J Cancer. 1995 Sep;72(3):555-61.

11.

The toxicity of aromatic nitrocompounds to bovine leukemia virus-transformed fibroblasts: the role of single-electron reduction.

Cènas N, Nemeikaitè A, Dickancaitè E, Anusevicius Z, Nivinskas H, Bironaitè D.

Biochim Biophys Acta. 1995 Aug 31;1268(2):159-64.

PMID:
7662703
12.
13.

Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism.

Cadenas E.

Biochem Pharmacol. 1995 Jan 18;49(2):127-40. Review. No abstract available.

PMID:
7530954
14.

NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity.

Traver RD, Horikoshi T, Danenberg KD, Stadlbauer TH, Danenberg PV, Ross D, Gibson NW.

Cancer Res. 1992 Feb 15;52(4):797-802.

15.

DT-diaphorase and cancer chemotherapy.

Riley RJ, Workman P.

Biochem Pharmacol. 1992 Apr 15;43(8):1657-69. Review. No abstract available.

PMID:
1575764

Supplemental Content

Support Center